Among the 15 patients who received mTOR inhibitors after PTLD (11 from conversion while 4 already on mTOR inhibitors before cancer), 11 patients died (9 due to sepsis, 1 due to ischemic heart disease, 1 due to cancer progression). This evidence concerns the gene MTOR and coronary artery disorder.